MRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Marathon Oil Corporation Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Marathon Oil Corporation (NYSE: MRO) to... Read more.
Alliance Resource Partners, L.P. Announces Private Offering of Senior Notes
TULSA, Okla.–(BUSINESS WIRE)–Alliance Resource Partners, L.P. (NASDAQ: ARLP) (“ARLP”) announced today that Alliance Resource Operating Partners,... Read more.
Memorial Credit Union Selects Mahalo Banking to Redesign its Digital Banking Experience
Credit union overhauls digital banking solution, thoughtfully improving member experience TROY, Mich.–(BUSINESS WIRE)–#banking–Mahalo Banking today... Read more.
New Barnes & Noble College Research Reveals Students’ Evolving Attitudes Towards Collegiate Retail
Research findings reveal the growing importance of convenience, elevated experiences, and dedicated service and support. Students continue to view the campus bookstore... Read more.
Introducing The World’s First AI Call Scanner by Truecaller: The Fastest & Most Accurate AI Voice Scam Detection System
WASHINGTON–(BUSINESS WIRE)–$TRUEB #AI–Three seconds! That’s how much of your voice an AI voice synthesizer needs to generate a complete clone... Read more.
Driven Brands to Present at the William Blair Growth Stock Conference
CHARLOTTE, N.C.–(BUSINESS WIRE)–Driven Brands Holdings Inc. (NASDAQ: DRVN) (“Driven Brands” or the “Company”) today announced that it will present... Read more.
enGene to Present at the Jefferies Global Healthcare Conference
BOSTON & MONTREAL–(BUSINESS WIRE)–enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage genetic medicines company... Read more.
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
– Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 – – Ellen James, Director, Clinical Development, to... Read more.
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment of Patients With Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
Acceptance based on results from the pivotal Phase 3 CCTG IND.227/KEYNOTE-483 trial, which demonstrated a statistically significant improvement in overall survival... Read more.
SoSafe Announces New Executive Advisors as Company Expands Category and Product Leadership
COLOGNE, Germany–(BUSINESS WIRE)–#Cyber–SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed four new... Read more.